Can You Take Sermorelin and Testosterone Together? What Providers Consider

If you’ve been researching hormone optimization, you may now be asking whether you can take sermorelin and testosterone together. After all, both therapies often come up in conversations about age-related hormone decline, and at first glance, their goals appear to overlap.

But the answer isn’t a simple yes or no. 

Whether these two therapies belong in the same protocol depends entirely on what a licensed healthcare provider evaluates about your individual health profile. This article explores how sermorelin and testosterone work, why some providers may consider them complementary, and the factors that go into that decision before either is recommended.

‍

How Sermorelin and Testosterone Work: Two Different Pathways

Sermorelin and testosterone don’t work through the same mechanism. And this is why they may be used together. So, what is sermorelin exactly?

Sermorelin is a synthetic peptide that mimics growth hormone-releasing hormone (GHRH), the signal your hypothalamus naturally produces. When administered, it tells the anterior pituitary gland to make and release more of your body’s own growth hormone (GH) in a natural, pulsatile pattern. 

Essentially, sermorelin stimulates your body’s own GH production rather than directly replacing GH. Because of this, your natural feedback systems—including somatostatin, which acts as a brake—remain intact and may help prevent excessive GH release.

In contrast, testosterone is the primary androgen responsible for muscle protein synthesis, libido, bone density, mood, and energy. Testosterone replacement therapy (TRT) restores testosterone to a normal physiological range in individuals with a documented deficiency.

In summary, sermorelin acts on the GH/IGF-1 axis, while testosterone acts on androgen receptors. These are separate systems, which is why hormone therapy combinations like this may be considered together.

‍

What Sermorelin Does (and Doesn’t Do)

Sermorelin works upstream on growth hormone, not on the testes or the hypothalamic-pituitary-gonadal (HPG) axis that governs testosterone production.

With that said, the relationship isn’t entirely separate. GH and its downstream mediator, IGF-1, may indirectly support the broader hormonal environment. Some research also suggests IGF-1 may influence luteinizing hormone (LH) and follicle-stimulating hormone (FSH) activity, which in turn, may help signal testosterone production. 

But this is an indirect relationship, not a proven mechanism for boosting testosterone. At the end of the day, sermorelin’s primary job is GH stimulation, not testosterone augmentation.

‍

What Testosterone Replacement Therapy Does

Testosterone Replacement Therapy (TRT) directly restores testosterone to a normal physiological range in individuals with clinically low levels (hypogonadism). 

For context, testosterone in men tends to decline roughly 1-2% per year after age 30, a pattern documented in long-running research such as the Massachusetts Male Aging Study.

While TRT is prescribed only after bloodwork confirms a deficiency, it comes in many forms, including injections, gels, patches, and pellets. However, a licensed provider should always determine whether it makes sense for you and your situation, along with the aforementioned blood testing.

‍

Why Providers May Consider Both Therapies Together

Since sermorelin and testosterone address different hormonal systems, GH/IGF-1 and androgens, some providers may consider them complementary in select cases. At the end of the day, aging rarely affects just one hormonal axis. And this means that optimizing only one system may leave specific symptoms unaddressed.

Considering the stats, GH secretion declines about 14% per decade after age 30—a gradual process sometimes called somatopause. Meanwhile, testosterone declines about 1-2% per year. While these are two separate processes, they may occur in parallel. When a provider sees evidence of decline on both fronts, sermorelin with TRT may be considered.

‍

Potential Complementary Effects on Body Composition

Testosterone supports muscle protein synthesis through androgen receptor activation. But GH, stimulated by sermorelin, may promote fat metabolism through lipolysis and support muscle repair via IGF-1-mediated satellite cell activity. Specifically in fat tissue, testosterone may help limit visceral fat storage, and GH may stimulate fat breakdown.

Together, these effects may support body composition goals in some individuals when prescribed and monitored by a licensed healthcare provider. Yet, it’s worth noting that individual results vary widely and depend heavily on diet, exercise, and overall health. If you’re curious where your own baseline sits, Eden’s BMI calculator provides a simple starting point; however, always keep in mind that no therapy can replace the fundamentals.

‍

Potential Effects on Recovery and Sleep

Both low testosterone and low GH may contribute to poor recovery and disrupted sleep, but through different routes. GH is mostly released during deep sleep, which is why sermorelin is usually taken at bedtime to line up with your body’s natural release window. Testosterone, meanwhile, plays a role in muscle maintenance and recovery.

This means that someone already on TRT who reports poor sleep or sluggish recovery may have a concurrent GH decline that testosterone alone doesn’t address. In this scenario, a healthcare provider may consider adding sermorelin, though a proper evaluation ultimately determines whether it’s appropriate.

‍

Potential Effects on Bone Density and Metabolic Health

Both testosterone and GH/IGF-1 help keep your bones strong, but they do it in different ways; testosterone signals the cells that build bone, and IGF-1 helps your body lay down new bone tissue. If you’re worried about bone health on top of declining hormones, a licensed healthcare provider may look at whether further evaluation is appropriate. 

Similarly, both hormones also influence insulin sensitivity and metabolic function. As with everything else here, however, a licensed provider is your best resource for looking at your full health profile and making recommendations that are right for you. 

‍

What Providers Evaluate Before Recommending Combination Therapy

Combining hormone-related therapies is not a default protocol. It’s an individualized clinical decision. A licensed provider considers several factors before recommending either therapy, including your baseline lab work, symptom profile, health history, and more.

‍

Baseline Lab Work

Before recommending sermorelin, TRT, or both, a provider will typically review your bloodwork. Relevant markers may include:

• Total and free testosterone
• IGF-1 (used as a practical proxy for GH activity, since GH itself is released in pulses and hard to measure directly)
• LH and FSH (to determine whether low testosterone is primary or secondary)
• A complete metabolic panel
• And sometimes thyroid function

But this alone isn’t enough information to dictate treatment. Lab results are always interpreted alongside your symptoms.

‍

Symptom Profile and Health History

Your provider will also map your symptoms, including which ones are present, how long they’ve persisted, and whether they point more toward GH decline, testosterone decline, or both. 

Ultimately, some symptoms tend to overlap, such as fatigue, reduced muscle mass, and weight gain, and occur in both GH and testosterone decline. But there are other symptoms that may be more specific. For instance, libido and sexual function tend to be more testosterone-related, while sleep quality and recovery speed lean more GH-related. 

Your health history will also be taken into account, including cardiovascular health, any hormone-sensitive conditions, current medications, and lifestyle factors. And all of the above is why a thorough intake and consultation with a licensed healthcare provider is essential.

‍

Monitoring During Combination Therapy

If your provider does recommend both therapies, ongoing monitoring is an important part of the process. This may include periodic bloodwork to track IGF-1, testosterone, and hematocrit (a known consideration with TRT), along with dose adjustments over time. 

In fact, Eden’s model may include regular check-ins and 24/7 messaging with providers. Our process starts with a brief online intake. From there, Eden connects you with a licensed healthcare provider who will review your health history, symptoms, and more.

‍

Who May Be a Candidate (And Who May Not Be)

A licensed healthcare provider may consider whether further evaluation is appropriate if you have: 

• A documented or suspected decline in both testosterone and GH markers
• Symptoms spanning both axes (such as low libido, poor sleep, slow recovery, and body composition changes)
• No contraindications to either therapy

Yet, it may not be appropriate for:

• Individuals with normal testosterone and no clinical hypogonadism
• Individuals with certain cardiovascular or metabolic contraindications
• Individuals whose symptoms are already fully addressed by one therapy alone

With that said, individual candidacy is case-based and provider-determined.

‍

A Note on Safety and the Importance of Medical Supervision

A licensed healthcare provider can ultimately help evaluate the potential benefits and risks of either therapy based on your individual circumstances. 

Sermorelin’s mechanism (stimulating your own pituitary to release GH with somatostatin feedback still intact) may result in different safety considerations than direct HGH replacement because it stimulates the body’s natural growth hormone signaling pathway rather than replacing growth hormone directly. TRT, when prescribed for confirmed deficiency and properly monitored, requires ongoing medical supervision and monitoring. 

However, both therapies require proper clinical oversight. Without it, you risk inappropriate dosing, failure to identify contraindications, and missing early signs of adverse effects (such as sermorelin side effects). Eden’s model, in which we connect you with a licensed healthcare provider, is designed to provide this level of oversight. So, how do we do that?

‍

How Eden Approaches Sermorelin Therapy

Eden’s Sermorelin Injections program is a prescription, compounded peptide therapy dispensed through state-licensed U.S. pharmacies and delivered as a 5 mL (10 mg) vial with a home injection kit via free expedited shipping. At the same time, it’s worth noting that compounded medications are not FDA-approved and are prepared for an individual patient per a prescription from a licensed clinician. 

The process is fully online, from intake and prescription to delivery. You complete an online consultation with a licensed provider, and, if prescribed, receive dosing instructions determined by your licensed healthcare provider, and get medication that’s lab-tested for potency, sterility, endotoxins, and pH. 

While learning how sermorelin and testosterone work is a smart first step, the next step is to have a conversation with a licensed provider who can review your labs, symptoms, and health history. From there, they’ll determine what’s best for you.